Drug intelligence / Profile preview

OMP-GEL 01

Development stage: Unknown
Lead developer: Oxford Medical Products
Modality: Hydrogel Systems → Drug Delivery Systems, Small Molecules
Administration: Oral

Overview

OMP-GEL 01 is an **Oxford Medical Products** preclinical small-molecule combination product using the company's gastroretentive hydrogel drug-delivery technology. The disclosed information does not identify its active ingredients, molecular targets, therapeutic indication, or pharmacologic mechanism. Oxford Medical Products describes its OMP GEL platform as an orally administered, superporous dual-polymer hydrogel that expands in the stomach, retains drug payloads for a tunable period, and releases them toward the duodenum; it is being developed to support delivery of small molecules and biologics. ([oxfordmedicalproducts.com](https://www.oxfordmedicalproducts.com/oral-drug-delivery-1))

Beyond the preview

Go deeper on OMP-GEL 01.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OMP-GEL 01.

Explore the full profile